3-iodobenzylguanidine has been researched along with Paraganglioma in 177 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (9.04) | 18.7374 |
| 1990's | 23 (12.99) | 18.2507 |
| 2000's | 43 (24.29) | 29.6817 |
| 2010's | 67 (37.85) | 24.3611 |
| 2020's | 28 (15.82) | 2.80 |
| Authors | Studies |
|---|---|
| Eguchi, S; Hasegawa, D; Hasegawa, T; Ichihashi, Y; Kanomata, N; Narumi, S; Nozaki, T; Ono, R; Ozawa, M; Sato, T; Umehara, N; Yada, K | 1 |
| Abe, T; Fukuhara, S; Imamura, R; Ishikawa, T; Kiuchi, H; Nonomura, N; Takezawa, K; Uemura, M | 1 |
| Akatani, N; Higuchi, T; Hirata, K; Hiromasa, T; Inaki, A; Jinguji, M; Kayano, D; Kinuya, S; Kunita, Y; Mori, H; Shiga, T; Tomonaga, H; Tsushima, Y; Wakabayashi, H; Watanabe, S; Yamase, T | 1 |
| Amar, L; de Freminville, JB; Dominiczak, AF; Lopez, AG; Schlaich, M; Touyz, R | 1 |
| Lu, Y | 1 |
| Drubach, L; DuBois, SG; Janeway, KA; Kamihara, J; Krokhmal, AA; Kwatra, N; Voss, SD; Weldon, CB | 1 |
| Inaki, A; Kayano, D; Kinuya, S; Wakabayashi, H; Zhang, X | 1 |
| Bajnok, L; Benkő, I; Bódis, B; Gulyás, E; Kálmán, E; Kittka, B; Mezősi, E; Nemes, O; Schmidt, E; Semjén, D; Szabados, S; Szukits, S | 1 |
| Lollert, A; Miederer, M; Russo, A; Staatz, G | 1 |
| Di, XP; Li, X; Wu, K; Xiong, SC; Zhang, MN | 1 |
| Hahner, S; Hartrampf, PE; Schirbel, A; Werner, RA | 1 |
| Abe, T; Hirata, K; Kimura, R; Kudo, K; Shinohara, N; Takenaka, J; Uchiyama, Y; Watanabe, S | 1 |
| Alonso-Gordoa, T; Araujo-Castro, M; Martínez Lorca, A; Molina-Cerrillo, J; Pascual-Corrales, E | 1 |
| Chin, BB; Dillon, JS; DiPippo, VA; Jimenez, C; Noto, RB; Pryma, DA; Solnes, L; Stambler, N | 1 |
| Budny, B; Czepczyński, R; Dziuk, M; Majchrzak-Hernandez, M; Ruchała, M; Sawicka-Gutaj, N; Sałyga, A; Szczepanek-Parulska, E | 1 |
| Jimenez, C; Lu, Y | 1 |
| Jimenez, C; Lu, Y; Xu, G | 1 |
| Borges-Neto, S; Kane, A; Morse, MA; Thorpe, MP; Wong, T; Zhu, J | 1 |
| Agarwala, S; Arora, S; Bal, C; Khadgawat, R; Kumar, R; Passah, A; Tripathi, M | 1 |
| Parra, LA; Salomao, MA; Swanson, SK; Yang, M | 1 |
| Inoue, M; Kusunoki, M; Nagano, Y; Otake, K; Uchida, K | 1 |
| Cherian, KE; Johnson, JT; Kapoor, N; Paul, TV | 1 |
| Jimenez, C; Núñez, R; Wendt, R | 1 |
| Bhansali, A; Chhabra, A; Kumar, R; Nahar, U; Paul, N; Rai Mittal, B; Shukla, J; Singh, D; Singh, H; Vatsa, R; Walia, R | 1 |
| Del Rivero, J; Ilanchezhian, M; Jha, A; Pacak, K | 1 |
| Jungels, C; Karfis, I | 1 |
| Afonso, ACF; Almeida, MQ; Benedetti, AFF; Bezerra Neto, JE; Chambo, JL; Coura-Filho, GB; Fagundes, GFC; Ferrari, MSS; Fragoso, MCBV; Guimaraes, AG; Hoff, AO; Latronico, AC; Magalhães, ALF; Mendonca, BB; Montenegro, FLM; Mota, FT; Pereira, MAA; Petenuci, J; Siqueira, S; Srougi, V; Tanno, FY; Zerbini, MCN | 1 |
| Bushnell, D; Dillon, JS; Laux, DE | 1 |
| Chen, L; Jing, H; Li, F; Zheng, K; Zhu, S | 1 |
| Huo, L; Jing, H; Li, F; Li, W; Wang, L; Wang, Z; Zhang, J | 1 |
| Higuchi, T; Imai, Y; Inaki, A; Jinguji, M; Kinuya, S; Kuribayashi, Y; Murayama, T; Shiga, T; Yoshimura, K | 1 |
| Goldsmith, SJ; Jensen, J; Lin, T; Noto, RB; Pryma, DA; Stambler, N; Strack, T; Wong, V | 1 |
| Gawlik, T; Handkiewicz-Junak, D; Hasse-Lazar, K; Jarząb, B; Jurecka-Lubieniecka, B; Kotecka-Blicharz, A; Krajewska, J; Michalik, B; Oczko-Wojciechowska, M; Pawlaczek, A; Szpak-Ulczok, S | 1 |
| Apfel, S; Armor, T; Chin, BB; Dillon, JS; DiPippo, VA; Jensen, J; Jimenez, C; Kostakoglu, L; Lin, T; Mahmood, S; Noto, RB; Pampaloni, MH; Perkins, S; Pryma, DA; Serafini, AN; Solnes, L; Stambler, N; White, T; Wong, V | 1 |
| Bosserman, AJ; Dai, D; Lu, Y | 1 |
| Gotoh, M; Kato, M; Kobayashi, H; Matsukawa, Y; Yamamoto, T; Yamauchi, Y; Yoshino, Y | 1 |
| Barron, BJ; Harrison, CE | 1 |
| Bal, C; Dhull, VS; Karunanithi, S; Kumar, R; Malhotra, A; Naswa, N; Reddy, RM; Sharma, P; Singh, H; Suman K C, S; Thakar, A | 1 |
| Casey, R; Maher, M; Moore, M; O'Halloran, D; Prendeville, S; Slattery, D | 1 |
| Cohen, DL; Fishbein, L | 1 |
| Castaldi, P; Giordano, A; Perotti, G; Rufini, V; Treglia, G | 1 |
| Aktolun, C; Aliberti, GL; Bombardieri, E; Buzzoni, R; Castellani, MR; Chiesa, C; Lorenzoni, A; Maccauro, M; Seregni, E; Vellani, C | 1 |
| Castellani, R; Chiesa, C; Flux, GD; Lorenzoni, A; Mira, M | 1 |
| Fukuoka, M; Inaki, A; Kayano, D; Kinuya, S; Matsuo, S; Nakajima, K; Nakamura, A; Taki, J; Wakabayashi, H | 1 |
| Corssmit, EP; Dekkers, OM; Niemeijer, ND; van Hulsteijn, LT | 1 |
| Einspieler, I; Essler, M; Martignoni, ME; Novotny, A; Okur, A | 1 |
| Bombardieri, E; Chiti, A; Lorenzoni, A; Pepe, G | 1 |
| Fukuoka, M; Higuchi, T; Inaki, A; Ito, YM; Jinguji, M; Kayano, D; Kinuya, S; Nakajo, M; Okamoto, S; Oriuchi, N; Shiga, T; Tomiyama, Y; Toratani, A; Wakabayashi, H; Yoshinaga, K | 1 |
| Jordan, A; Seltzer, M; Siegel, A | 1 |
| Freel, EM; Mark, PB; Perry, CG; Rankin, AJ; Reed, NS; Rutherford, MA; Yates, TM | 1 |
| Bandgar, T; Kasaliwal, R; Lila, A; Malhotra, G; Shah, NS | 1 |
| Antoniewicz, J; Bednarek-Tupikowska, G; Buscombe, JR; Cichocki, A; Ćwikła, JB; Furmanek, MI; Janas, J; Janaszek-Sitkowska, H; Januszewicz, A; Kabat, M; Kawecki, A; Lewczuk, A; Malinoc, A; Michalski, W; Michałowska, I; Moczulski, D; Neumann, HP; Otto, M; Pęczkowska, M; Pęczkowski, P; Prejbisz, A; Przybyłowska, K; Szperl, M; Szutkowski, Z | 1 |
| Gotthardt, M; Hermus, AR; Janssen, MJ; Kusters, B; Langenhuijsen, JF; Lenders, JW; Pellegata, NS; Piscaer, I; Plantinga, TS; Rao, JU; Timmers, HJ; van Berkel, A; Vriens, D | 1 |
| Agrawal, K; Bomanji, J; Gavra, M; Sajjan, RS; Syed, R | 1 |
| Baba, S; Hida, T; Honda, H; Kamitani, T; Kawanami, S; Kohashi, K; Nagao, M; Nakamura, K; Oda, Y; Sonoda, H; Takashima, Y; Yabuuchi, H; Yamasaki, Y; Yonezawa, M | 1 |
| Angelousi, A; Kaltsas, G; Kassi, E; Zografos, G | 1 |
| Afonso, M; Almeida, M; Pinto, A; Teixeira, J | 1 |
| Bomanji, J; Bouloux, P; Caplin, M; Conway, G; Ezzat Abdel-Aziz, T; Gaze, M; Khoo, B; Kurzawinski, TR; Mushtaq, I; Prete, F; Smart, J | 1 |
| Hicks, RJ; Pacak, K; Taïeb, D | 1 |
| Cai, Y; Li, HZ; Zhang, YS | 1 |
| Bai, X; Zhuang, H | 2 |
| Carrasquillo, JA; Cheung, NK; Kramer, K; Kushner, BH; Larson, SM; Modak, S; Pandit-Taskar, N; Zanzonico, P | 1 |
| Barank, D; Cho, J; Davalos, EA; Dave, H; Shen, H; Shim, J | 1 |
| Carrasquillo, JA; Chen, CC; Pandit-Taskar, N | 1 |
| Patócs, A; Tóth, G; Tóth, M | 1 |
| Ishimori, T; Nakamoto, R; Nakamoto, Y; Togashi, K | 1 |
| Almenara, R; Lacy, A; Momblán, D; Navarrete, A | 1 |
| Caplin, M; Cheung, VTF; Khoo, B; Nastos, K; Navalkissoor, S; Quigley, AM; Toumpanakis, C | 1 |
| Darvishi, P; Mithqal, A; Rehm, P | 1 |
| Amanuma, M; Arisaka, Y; Endo, K; Higuchi, T; Nakajima, T; Oriuchi, N; Takano, A; Taketomi-Takahashi, A; Tsushima, Y | 1 |
| Albers, F; Dullaart, RP; Jager, PL; Kema, IP; Kerstens, MN; Koopmans, KP | 1 |
| Corssmit, EP; Havekes, B; Lai, EW; Pacak, K; Romijn, JA; Timmers, HJ | 1 |
| Brouwers, AH; de Jong, JR; de Vries, EG; Dierckx, RA; Elsinga, PH; Fiebrich, HB; Jager, PL; Kema, IP; Kerstens, MN; Links, TP; Pijl, ME; Sluiter, WJ; van der Wal, JE | 1 |
| Damon, L; Fitzgerald, P; Goldsby, R; Gonias, S; Hawkins, R; Huberty, J; Linker, C; Matthay, KK; Price, D; Shiboski, S; Sznewajs, A | 1 |
| Heiba, SI; Jacobson, AF; Khutoryansky, N; Mankoff, DA; Neumann, DR; O'Dorisio, MS; Pacak, K; Serafini, AN; Tumeh, SS; Waxman, AD; Wiseman, GA | 1 |
| Babich, JW; Barrett, JA; Coleman, RE; de la Guardia, M; Lafrance, N; Stubbs, JB | 1 |
| Bar-Deroma, R; Bar-Sela, G; Berniger, A; Kuten, A; Shilkrut, M | 1 |
| Abo, H; Ishikura, K; Kahara, T; Nakajima, K; Seto, C; Uchiyama, A; Usuda, R; Watanabe, S | 1 |
| Corssmit, EP; Milardovic, R; Stokkel, M | 1 |
| Adams, KT; Carrasquillo, JA; Chen, CC; Eisenhofer, G; Havekes, B; Ling, A; Martiniova, L; Pacak, K; Timmers, HJ; Whatley, M | 1 |
| McEwan, AJ; Postema, EJ | 1 |
| Fukuhara, T; Hanaoka, T; Hirasaki, S; Kanzaki, H; Okuda, M; Suzuki, S | 1 |
| Bayley, JP; Corssmit, EP; Jansen, JC; Kema, IP; Romijn, JA; Smit, JW; Steenvoorden, D; van Duinen, N; Vriends, AH | 1 |
| Beasley, A; Burgess, JR; Dubey, A; Erasmus, AM; Hunn, AW; Jessup, PJ; Kwan, RB; Waites, P | 1 |
| Ayala-Ramirez, M; Callender, GG; Chuang, HH; Goodarzi, M; Jimenez, C; Kupferman, ME; Perrier, ND; Rich, TA; Trent, J | 1 |
| Berthold, F; Eschner, W; Schicha, H; Schmidt, M; Simon, T; Sudbrock, F | 1 |
| Chew, SL | 2 |
| Anlauf, M; Bartenstein, P; Fottner, C; Helisch, A; Klöppel, G; Kreft, A; Lackner, KJ; Musholt, TJ; Rossmann, H; Schadmand-Fischer, S; Schreckenberger, M; Weber, MM | 1 |
| Deng, JH; Li, HZ; Liu, GH; Zhang, YS | 1 |
| Altaf, R; Andersen, KF; Christensen, NJ; Hendel, HW; Horn, T; Krarup-Hansen, A; Kromann-Andersen, B | 1 |
| Al-Nahhas, A; Ferrarese, A; Meades, R; Naji, M; Rubello, D; Tan, T; Welsh, SJ; Win, Z; Zhao, C | 1 |
| Fukuoka, M; Kinuya, S; Mochizuki, T; Taki, J | 1 |
| Calcagni, ML; Castaldi, P; Corsello, SM; Fanti, S; Galli, G; Giordano, A; Perotti, G; Rufini, V; Treglia, G | 1 |
| Adams, KT; Alexopoulos, DK; Chen, CC; King, KS; Lando, H; Ling, A; Pacak, K; Patronas, N; Reynolds, JC; Stratakis, CA; Whatley, MA; Xekouki, P | 1 |
| Huan, L; Jaffe, BM; Kandil, E | 1 |
| Fukuoka, M; Inaki, A; Kayano, D; Kinuya, S; Nakamura, A; Taki, J; Wakabayashi, H | 1 |
| Adams, KT; Chen, CC; Fojo, T; Fonte, JS; Ling, A; Martucci, V; Mercado-Asis, LB; Pacak, K; Reynolds, J; Robles, JF; Whatley, M | 1 |
| Amanuma, M; Higuchi, T; Nakano, S; Taketomi-Takahashi, A; Tsushima, Y | 1 |
| Biersack, HJ; Ezziddin, S; Ko, YD; Matthies, A; Sabet, A; Xun, S | 1 |
| Bomanji, JB; Papathanasiou, ND | 1 |
| Adams, KT; Carrasquillo, JA; Chen, CC; Eisenhofer, G; King, KS; Ling, A; Pacak, K; Rao, JU; Timmers, HJ; Wesley, RA; Whatley, M | 1 |
| Al-Nahhas, A; Dhillo, W; Goldstone, AP; Martin, NM; Maurice, JB; Meeran, K; Naji, M; Palazzo, F; Ramachandran, R; Tan, T; Todd, JF; Troke, R; Win, Z | 1 |
| Bonner, L; Cengel, KA; Cohen, DL; Fishbein, L; Nathanson, KL; Pryma, D; Torigian, DA | 1 |
| Cuccurullo, V; Mansi, L | 1 |
| Dean, DS; Hardegree, EL; Maleszewski, JJ; Nishimura, RA; Patel, SM | 1 |
| Hsu, LH; Hsu, WH; Tsou, MH; You, DL | 1 |
| Blin, V; Enon, B; Picquet, J; Rohmer, V | 1 |
| Chai, CY; Kang, WY; Shen, JT | 1 |
| Fitzgerald, PA; Huberty, J; Klencke, B; Matthay, KK; Norton, JA; Price, D; Rose, B | 1 |
| Coleman, RE; Feldman, JM; Gockerman, JP; Leight, GS; Moore, J; Olson, JA; Safford, SD; Tyler, DS | 1 |
| Behr, TM; Döbert, N; Gotthard, M; Grünwald, F; Hamscho, N; Kranert, WT; Menzel, C; Zaplatnikov, K | 1 |
| Roman, S; Yeo, H | 1 |
| Biondi, B; Fazio, S; Lombardi, G; Pagano, L; Palmieri, EA; Pulcrano, M; Rossi, A; Tauchmanova, L | 1 |
| Buonuomo, V; D'Urzo, C; Manzoni, C; Pintus, C; Rando, G; Ruggiero, A | 1 |
| Cardot-Bauters, C; Huglo, D; Lamblin, A; Leteurtre, E; Mondragon-Sanchez, A; Pattou, F; Pigny, P; Porchet, N; Proye, C; Rouaix-Emery, N; Tex, G; Wemeau, JL | 1 |
| Chan, MH; Fung, LM; Lam, CW; Ng, KF; Tam, S; Tam, V; Wong, YY | 1 |
| Bley, TA; Brink, I; Hoegerle, S; Klisch, J | 1 |
| Borson-Chazot, F; Giammarile, F | 1 |
| Avram, AM; Fig, LM; Gross, MD | 1 |
| Baum, RP; Calcagni, ML; Rufini, V | 1 |
| Damon, L; Dela Cruz, F; Fitzgerald, PA; Goldsby, RE; Hawkins, RA; Huberty, JP; Jahan, TM; Linker, CA; Matthay, KK; Price, DC; Veatch, JJ | 1 |
| Bae, SJ; Chung, JH; Jung, HS; Kim, KW; Lee, MK; Lee, MS; Min, YK; Park, HK; Park, S; Yang, JH | 1 |
| Adams, KT; Carrasquillo, JA; Chen, CC; Eisenhofer, G; Kozupa, A; Lenders, JW; Ling, A; Pacak, K; Solis, D; Timmers, HJ | 1 |
| Hirata, K; Inoue, T; Kanegae, K; Morita, K; Okamoto, S; Shiga, T; Tamaki, N; Yoshinaga, K | 1 |
| Huang, W; Lew, JI; Montano, R; Prinz, RA; Sleeman, D; Solorzano, CC; Sumner, W; Wilhelm, SM; Wu, W | 1 |
| Bais, E; Gedik, GK; Hoefnagel, CA; Olmos, RA | 1 |
| Juergens, KU; Kies, P; Rahbar, K; Stegger, L; Weckesser, M | 1 |
| Adams, KT; Carrasquillo, JA; Chen, CC; Eisenhofer, G; Kozupa, A; Lazúrová, I; Ling, A; Pacak, K; Reynolds, JC; Timmers, HJ; Whatley, MA; Widimsky, J; Zelinka, T | 1 |
| Alamán Orbañanos, B; Becerra Cayetano, A; Martín-Romo Capilla, J; Negrete Calderón, N | 1 |
| Baulieu, F; Baulieu, JL; Caron, J; Fetissof, F; Guilloteau, D; Guilmot, JL; Itti, R; Lecomte, P; Lipinski, F; Pourcelot, L | 1 |
| Hollema, H; Muskiet, FA; Piers, DA; Smit, AJ; van Essen, LH | 1 |
| Caillou, B; Lumbroso, J; Mure, A; Parmentier, C; Plouin, PF; Schlumberger, M; Tenenbaum, F | 1 |
| Crespo, A; Diez, L; Lancha, C; Mitjavila, M; Rueda, M | 1 |
| Hattner, RS; Matthay, KK; Pounds, TR | 1 |
| Cuocolo, A; Keiser, H; Maurea, S; Neumann, R; Reynolds, J; Salvatore, M | 1 |
| Falke, TH; Pauwels, EK; van Erkel, AR; van Gils, AP | 1 |
| Besser, GM; Bomanji, J; Britton, KE; Grossman, AB; Hawkins, L; Ur, E | 1 |
| Coutris, G; Mensch, B; Montravers, F; Sarda, L; Talbot, JN | 1 |
| Begley, MG; Cuocolo, A; Keiser, HR; Linehan, WM; Maurea, S; Neumann, RD; Norton, JA; Reynolds, JC; Tumeh, SS; Walther, MM | 1 |
| Heufelder, AE; Hofbauer, LC | 1 |
| Arsena, T; Başoğlu, T; Bertrand, A; Karcher, G; Marie, PY; Olivier, P; Schlienger, JL | 1 |
| Carnaille, B; Combemale, FP; Ernst, O; Huglo, D; Pattou, FN; Poirette, JF; Proye, CA; Wemeau, JL | 1 |
| Gross, MD; Shapiro, B; Shulkin, BL; Sisson, JC; Zempel, S | 1 |
| Han, R; Mitrovic, S; Zagar, I | 1 |
| Cuocolo, A; Maurea, S; Neumann, RD; Reynolds, JC; Salvatore, M | 1 |
| Beijnen, JH; Hoefnagel, CA; Maes, RA; Maessen, HJ; Wafelman, AR | 1 |
| Gonzalez, E; Markel, SF; McHugh, T; Shapiro, B; Weissman, A | 1 |
| Grimelius, L; Jacobsson, H; Larsson, SA; Svartberg, J; Wallin, G | 1 |
| Caballero, C; Cordero, J; Crespo, A; Díez, L; Rioja, M | 1 |
| Carnaille, B; Combemale, F; Huglo, D; Nguyen, HH; Pattou, FN; Proye, CA | 1 |
| Arver, S; Brismar, K; Cedermark, B; Grimelius, L; Hamberger, B; Jacobsson, H; Lundell, G | 1 |
| Engelhardt, D; Rau, HG; Ritter, MM; Szukics, B | 1 |
| Besser, GM; Britton, KE; Chew, SL; Foley, R; Grossman, AB; Heintz, E; Jenkins, PJ; Kaltsas, G; Korbonits, M; Monson, JP; Mukherjee, JJ; Reznek, R | 1 |
| Bomanji, JB; Costa, DC; Coulter, C; Ell, PJ; Gacinovic, S; Gaze, MN; Hyder, SW | 1 |
| Bomanji, JB; Costa, DC; Ell, PJ; Le Rest, C; Townsend, CE; Visvikis, D | 1 |
| Besser, GM; Britton, KE; Chew, SL; Foley, R; Grossman, AB; Hikmat, J; Islam, N; Jenkins, PJ; Kaltsas, GA; Monson, JP; Mukherjee, JJ; Plowman, PN | 1 |
| Fukuchi, K; Hayashida, K; Horita, Y; Inenaga, T; Ishida, Y; Suzuki, Y | 1 |
| Ouaknine, GE; Rochkind, S; Salame, K; Yossipov, J | 1 |
| Cornford, EJ; Morgan, DA; Wastie, ML | 1 |
| Ball, AB; Fisher, C; Harmer, CL; Sinnett, HD; Tait, DM | 1 |
| Delree, M; Desprechins, B; Ferster, A; Ham, HR; Jacobs, A; Jonckheer, MH; Mertens, J; Otten, J; Piepsz, A | 1 |
| Allison, RW; Egerton-Vernon, J; Foster, W; Khafagi, F; McPhee, IB; van Doorn, T | 1 |
| Besser, GM; Bomanji, J; Britton, KE; Harris, P; Ross, G; Sinclair, AJ | 1 |
| Bomanji, J; Britton, KE; Conry, BG; Reznek, RH | 1 |
| Arnold, RW; Chan, R; Scott, J; Warshawski, RS | 1 |
| Beals, E; Beierwaltes, WH; Gross, MD; Lloyd, R; McEwan, AJ; Shapiro, B; Sisson, JC; Thompson, NW; Von Moll, L | 1 |
| Baulieu, F; Baulieu, JL; Besnard, JC; Chambon, C; Guilloteau, D; Le Floch, O; Pourcelot, L | 1 |
| Abe, T; Fujimori, M; Kamimura, A; Kanaya, H; Kato, M; Ohira, A; Otokida, K; Saiki, I; Takahashi, A; Tashiro, A | 1 |
| Besser, GM; Bomanji, J; Bouloux, PM; Britton, KE; Flatman, WD; Horne, T; Levison, DA; Ross, G | 2 |
| Itoh, K; Koyanagi, T; Maru, A; Sakashita, S; Tanda, K; Togashi, M; Tsukamoto, E | 1 |
| Chenevert, TL; Francis, IR; Glazer, GM; Quint, LE; Shapiro, B | 1 |
| Amparo, EG; Conti, VR; Saydjari, R | 1 |
| Brown, ML; Gharib, H; Grant, CS; Sheps, SG; Sizemore, GW; Swensen, SJ; van Heerden, JA | 1 |
| Brown, ML; Sheps, SG | 1 |
28 review(s) available for 3-iodobenzylguanidine and Paraganglioma
| Article | Year |
|---|---|
I-131 metaiodobenzylguanidine therapy is a significant treatment option for pheochromocytoma and paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Humans; Iodine Radioisotopes; Paraganglioma; Pheochromocytoma; Radiopharmaceuticals | 2022 |
[Pheochromocytoma and paraganglioma during childhood and adolescence].
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Catecholamines; Humans; Paraganglioma; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed | 2022 |
Adrenal functional imaging - which marker for which indication?
Topics: 3-Iodobenzylguanidine; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Biomarkers; Fluorodeoxyglucose F18; Glucose Transport Proteins, Facilitative; Humans; Norepinephrine Plasma Membrane Transport Proteins; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Chemokine; Receptors, Somatostatin | 2022 |
Role of imaging test with radionuclides in the diagnosis and treatment of pheochromocytomas and paragangliomas.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Humans; Paraganglioma; Pheochromocytoma; Radiopharmaceuticals | 2022 |
High-specific-activity iodine 131 metaiodobenzylguanidine for the treatment of metastatic pheochromocytoma or paraganglioma: a novel therapy for an orphan disease.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Carcinoma, Neuroendocrine; Humans; Intestinal Neoplasms; Iodine Radioisotopes; Neoplasm Metastasis; Neuroblastoma; Neuroendocrine Tumors; Pancreatic Neoplasms; Paraganglioma; Pheochromocytoma; Rare Diseases; Stomach Neoplasms; Therapies, Investigational; Thyroid Neoplasms | 2020 |
Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Cytoreduction Surgical Procedures; Dacarbazine; Everolimus; Humans; Liver Neoplasms; Lung Neoplasms; Octreotide; Paraganglioma; Pheochromocytoma; Poly(ADP-ribose) Polymerase Inhibitors; Radiopharmaceuticals; Surgical Procedures, Operative; Vincristine | 2020 |
131I-metaiodobenzylguanidine and peptide receptor radionuclide therapy in pheochromocytoma and paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Humans; Iodine Radioisotopes; Paraganglioma; Pheochromocytoma; Radiopharmaceuticals; Receptors, Peptide | 2021 |
Comparison of metaiodobenzylguanidine scintigraphy with positron emission tomography in the diagnostic work-up of pheochromocytoma and paraganglioma: a systematic review.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Humans; Paraganglioma; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2013 |
Iodine-131 metaiodobenzylguanidine (I-131 MIBG) diagnosis and therapy of pheochromocytoma and paraganglioma: current problems, critical issues and presentation of a sample case.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Humans; Image Enhancement; Male; Middle Aged; Paraganglioma; Radionuclide Imaging; Radiopharmaceuticals; Treatment Outcome | 2013 |
Dosimetry in 131I-mIBG therapy: moving toward personalized medicine.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Humans; Paraganglioma; Precision Medicine; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided | 2013 |
(131)I-MIBG therapy for malignant paraganglioma and phaeochromocytoma: systematic review and meta-analysis.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Bias; Humans; Iodine Radioisotopes; Paraganglioma; Pheochromocytoma; Tumor Burden | 2014 |
Single-photon emission computed tomography tracers in the diagnostics of neuroendocrine tumors.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Carcinoma, Neuroendocrine; Contraindications; Humans; Intestinal Neoplasms; Lung Neoplasms; Neuroblastoma; Neuroendocrine Tumors; Pancreatic Neoplasms; Paraganglioma; Pheochromocytoma; Pituitary Neoplasms; Radiopharmaceuticals; Receptors, Somatostatin; Somatostatin; Stomach Neoplasms; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon | 2014 |
Metastatic pheochromocytoma and paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Mutation; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Succinate Dehydrogenase; Tomography, X-Ray Computed | 2015 |
I-131 Metaiodobenzylguanidine Therapy of Pheochromocytoma and Paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Humans; Paraganglioma; Pheochromocytoma | 2016 |
Detection and treatment of pheochromocytomas and paragangliomas: current standing of MIBG scintigraphy and future role of PET imaging.
Topics: 3-Iodobenzylguanidine; Humans; Iodine Radioisotopes; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography | 2008 |
Radioiodinated metaiodobenzylguanidine treatment of neuroendocrine tumors in adults.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Algorithms; Carcinoid Tumor; Carcinoma, Medullary; Drug Interactions; Humans; Iodine Radioisotopes; Male; Medical Oncology; Neuroendocrine Tumors; Paraganglioma; Pheochromocytoma; Radiopharmaceuticals; Thyroid Neoplasms | 2009 |
Malignant pheochromocytomas and paragangliomas - the importance of a multidisciplinary approach.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Humans; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Prognosis; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2011 |
¹¹¹In-DTPA⁰-octreotide (Octreoscan), ¹³¹I-MIBG and other agents for radionuclide therapy of NETs.
Topics: 3-Iodobenzylguanidine; Carcinoid Tumor; Carcinoma, Neuroendocrine; Humans; Iodine Radioisotopes; Neuroendocrine Tumors; Octreotide; Paraganglioma; Pentetic Acid; Pheochromocytoma; Radiopharmaceuticals; Receptors, Somatostatin; Thyroid Neoplasms | 2012 |
Recent developments in the therapy of phaeochromocytoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Catecholamines; Combined Modality Therapy; Humans; Paraganglioma; Pheochromocytoma | 2004 |
Pheochromocytoma and functional paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Chromaffin Cells; Diagnosis, Differential; Humans; Magnetic Resonance Imaging; Paraganglioma; Pheochromocytoma; Radiopharmaceuticals; Tomography, X-Ray Computed | 2005 |
Malignant retroperitoneal paraganglioma: case report and review of the literature.
Topics: 3-Iodobenzylguanidine; Child; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Paraganglioma; Remission Induction; Retroperitoneal Neoplasms; Tomography, Emission-Computed | 2004 |
Imaging of pheochromocytoma and paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
[Neuroendocrine tumours treated with mIBG and radiolabeled peptides].
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Carcinoma, Neuroendocrine; Combined Modality Therapy; Humans; Neuroblastoma; Paraganglioma; Peptides; Prognosis; Radiopharmaceuticals | 2006 |
Adrenal gland scintigraphy.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenal Glands; Cushing Syndrome; Female; Fluorodeoxyglucose F18; Humans; Hyperaldosteronism; Incidental Findings; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Ultrasonography; Virilism | 2006 |
Imaging of neuroendocrine tumors.
Topics: 3-Iodobenzylguanidine; ACTH Syndrome, Ectopic; Adrenal Gland Neoplasms; Adult; Carcinoma, Medullary; Catecholamines; Child; Gastrointestinal Neoplasms; Humans; Iodine Radioisotopes; Middle Aged; Neuroblastoma; Neuroendocrine Tumors; Octreotide; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Somatostatin; Thyroid Neoplasms | 2006 |
Magnetic resonance imaging or metaiodobenzylguanidine scintigraphy for the demonstration of paragangliomas? Correlations and disparities.
Topics: 3-Iodobenzylguanidine; Humans; Iodobenzenes; Magnetic Resonance Imaging; Paraganglioma; Radionuclide Imaging | 1994 |
The current status of meta-iodobenzylguanidine and related agents for the diagnosis of neuro-endocrine tumors.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Carcinoid Tumor; Carcinoma, Medullary; Heart; Hormone Antagonists; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Neuroendocrine Tumors; Paraganglioma; Pheochromocytoma; Radiology, Interventional; Radiopharmaceuticals; Sensitivity and Specificity; Somatostatin; Sympathetic Nervous System; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1995 |
Malignant paraganglioma of the prostate: case report, depiction by meta-iodobenzylguanidine scintigraphy and review of the literature.
Topics: 3-Iodobenzylguanidine; Adolescent; Biopsy; Humans; Iodine Radioisotopes; Iodobenzenes; Lymphatic Metastasis; Male; Paraganglioma; Prostate; Prostatic Neoplasms; Tomography, Emission-Computed, Single-Photon; Ultrasonography | 1997 |
11 trial(s) available for 3-iodobenzylguanidine and Paraganglioma
| Article | Year |
|---|---|
An open-label, single-arm, multi-center, phase II clinical trial of single-dose [
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Humans; Iodine Radioisotopes; Paraganglioma; Pheochromocytoma | 2022 |
Role of [68Ga]DOTANOC PET/computed tomography and [131I]MIBG scintigraphy in the management of patients with pheochromocytoma and paraganglioma: a prospective study.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Female; Humans; Male; Middle Aged; Mutation; Organometallic Compounds; Paraganglioma; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Prospective Studies; Young Adult | 2020 |
A phase I clinical trial for [
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Clinical Protocols; Humans; Paraganglioma; Pheochromocytoma; Prospective Studies; Radiopharmaceuticals | 2017 |
Phase 1 Study of High-Specific-Activity I-131 MIBG for Metastatic and/or Recurrent Pheochromocytoma or Paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Dose-Response Relationship, Radiation; Female; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Paraganglioma; Pheochromocytoma; Prognosis; Survival Rate | 2018 |
Efficacy and Safety of High-Specific-Activity
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Biomarkers, Tumor; Female; Humans; Male; Paraganglioma; Pheochromocytoma; Safety; Survival Analysis; Treatment Outcome | 2019 |
Arsenic Trioxide as a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II Study.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Arsenic Trioxide; Arsenicals; Brain Neoplasms; Child; Child, Preschool; Drug Resistance, Neoplasm; Female; Humans; Male; Neuroblastoma; Oxides; Paraganglioma; Pheochromocytoma; Radiation-Sensitizing Agents; Radiopharmaceuticals; Survival Analysis; Treatment Outcome | 2016 |
Phase II study of high-dose [131I]metaiodobenzylguanidine therapy for patients with metastatic pheochromocytoma and paraganglioma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Biomarkers, Tumor; Catecholamines; Child; Chromogranin A; Disease-Free Survival; Dose-Response Relationship, Radiation; Female; Humans; Infusions, Intravenous; Iodine Radioisotopes; Kaplan-Meier Estimate; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Risk Assessment; Time Factors; Treatment Outcome; Young Adult | 2009 |
Radiation dosimetry, pharmacokinetics, and safety of ultratrace Iobenguane I-131 in patients with malignant pheochromocytoma/paraganglioma or metastatic carcinoid.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Dose-Response Relationship, Radiation; Female; Humans; Iodine Radioisotopes; Male; Paraganglioma; Pheochromocytoma; Radiation Dosage; Radiometry; Radiopharmaceuticals | 2009 |
Low-dose iodine-131 metaiodobenzylguanidine therapy for patients with malignant pheochromocytoma and paraganglioma: single center experience.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Antineoplastic Agents; Dose-Response Relationship, Radiation; Female; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Staging; Paraganglioma; Pheochromocytoma; Prognosis; Survival Rate; Treatment Outcome; Young Adult | 2010 |
Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG).
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Child; Diagnosis, Differential; Dose-Response Relationship, Radiation; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Paraganglioma; Pheochromocytoma | 2006 |
Tumour size: the only predictive factor for 131I MIBG uptake in phaeochromocytoma and paraganglioma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Child; Cross-Sectional Studies; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals | 1999 |
138 other study(ies) available for 3-iodobenzylguanidine and Paraganglioma
| Article | Year |
|---|---|
Hereditary paraganglioma presenting with atypical symptoms: Case report.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Catecholamines; Child; Headache; Humans; Male; Paraganglioma; Pheochromocytoma; Polyuria; Posterior Leukoencephalopathy Syndrome; Proteinuria; Radionuclide Imaging; Weight Loss | 2021 |
[A Case of Presacral Paraganglioma Resected by Laparoscopic Surgery].
Topics: 3-Iodobenzylguanidine; Adult; Female; Humans; Iodine Radioisotopes; Laparoscopy; Paraganglioma | 2021 |
Hypertension With Negative Metaiodobenzylguanidine Scintigraphy.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Diagnosis, Differential; Female; Humans; Hypertension, Pregnancy-Induced; Magnetic Resonance Imaging; Paraganglioma; Pheochromocytoma; Pregnancy; Pregnancy Complications, Neoplastic; Radionuclide Imaging | 2022 |
Heterogeneous Head and Neck Paraganglioma With Distinct Features on 123 I-MIBG and 68 Ga-DOTATATE Images.
Topics: 3-Iodobenzylguanidine; Adult; Carotid Body Tumor; Humans; Male; Organometallic Compounds; Paraganglioma; Paraganglioma, Extra-Adrenal; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals | 2022 |
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Child; Fluorodeoxyglucose F18; Humans; Paraganglioma; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed | 2022 |
Diagnostic difficulties and therapeutic options of a giant chest paraganglioma
Topics: 3-Iodobenzylguanidine; Adult; Humans; Iodine Radioisotopes; Male; Neoplasm Recurrence, Local; Paraganglioma | 2022 |
A rare case report of multifocal para-aortic and para-vesical paragangliomas.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Catecholamines; Humans; Male; Paraganglioma; Pheochromocytoma | 2022 |
Prognostic value of [
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Fluorodeoxyglucose F18; Glycolysis; Humans; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2023 |
Biomarker response to high-specific-activity I-131 meta-iodobenzylguanidine in pheochromocytoma/paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Biomarkers, Tumor; Chromogranin A; Humans; Iodine Radioisotopes; Metanephrine; Paraganglioma; Pheochromocytoma | 2023 |
[131I]I-MIBG-negative metastases of a recurrent sporadic paraganglioma in a female with achondroplasia.
Topics: 3-Iodobenzylguanidine; Achondroplasia; Adrenal Gland Neoplasms; Female; Humans; Iodine Radioisotopes; Neoplasm Recurrence, Local; Paraganglioma; Positron-Emission Tomography | 2023 |
Functional Imaging Evidence of Tumor Response to High-Specific-Activity 131 I-MIBG Therapy in an 84-Year-Old Patient With Metastatic Pheochromocytoma/Paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged, 80 and over; Brain Neoplasms; Humans; Male; Neoplasms, Second Primary; Paraganglioma; Peripheral Nervous System Neoplasms; Pheochromocytoma | 2023 |
Proposed MIBG Scan-Based Tumor Response Criteria of High-Specific-Activity 131 I-MIBG Therapy in Metastatic Pheochromocytoma/Paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Brain Neoplasms; Humans; Neoplasms, Second Primary; Neuroendocrine Tumors; Paraganglioma; Peripheral Nervous System Neoplasms; Pheochromocytoma | 2023 |
Long-Term Outcomes of 125 Patients With Metastatic Pheochromocytoma or Paraganglioma Treated With 131-I MIBG.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Disease Progression; Female; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2020 |
Prospective evaluation of 68Ga-DOTANOC positron emission tomography/computed tomography and 131I-meta-iodobenzylguanidine single-photon emission computed tomography/computed tomography in extra-adrenal paragangliomas, including uncommon primary sites and
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adolescent; Adult; Aged; Child; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Organometallic Compounds; Paraganglioma; Positron Emission Tomography Computed Tomography; Prospective Studies; Sensitivity and Specificity; Single Photon Emission Computed Tomography Computed Tomography; Young Adult | 2019 |
Multifocal Urinary Bladder Paragangliomas With Negative 68Ga-DOTATATE Uptake and Positive 123I-MIBG Uptake.
Topics: 3-Iodobenzylguanidine; Biological Transport; Humans; Male; Middle Aged; Organometallic Compounds; Paraganglioma; Positron Emission Tomography Computed Tomography; Receptors, Somatostatin; Urinary Bladder Neoplasms | 2020 |
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Basic Helix-Loop-Helix Transcription Factors; Humans; Kidney Neoplasms; Male; Mutation; Neoplasm Recurrence, Local; Paraganglioma; Pheochromocytoma; Polycythemia; Radionuclide Imaging; Radiopharmaceuticals; Young Adult | 2020 |
Micturition syncope secondary to urinary bladder paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenergic alpha-1 Receptor Antagonists; Adult; Diagnosis, Differential; Diagnostic Errors; Female; Humans; Hypertension; Normetanephrine; Paraganglioma; Prazosin; Preoperative Care; Syncope; Tomography, X-Ray Computed; Treatment Outcome; Urinary Bladder Neoplasms | 2020 |
SDHB large deletions are associated with absence of MIBG uptake in metastatic lesions of malignant paragangliomas.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Humans; Paraganglioma; Pheochromocytoma; Succinate Dehydrogenase | 2021 |
High-specific-activity
Topics: 3-Iodobenzylguanidine; Disease Management; Humans; Iodine Radioisotopes; Neoplasm Staging; Paraganglioma; Pheochromocytoma; Treatment Outcome | 2021 |
Paraganglioma From Vaginal Wall Revealed by 131I-MIBG Scan.
Topics: 3-Iodobenzylguanidine; Adult; Female; Humans; Paraganglioma; Radionuclide Imaging; Vaginal Neoplasms | 2021 |
Comparison of the 68Ga-DOTATATA PET/CT, FDG PET/CT, and MIBG SPECT/CT in the Evaluation of Suspected Primary Pheochromocytomas and Paragangliomas.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Organometallic Compounds; Paraganglioma; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Retrospective Studies; Single Photon Emission Computed Tomography Computed Tomography | 2017 |
131-I MIBG therapy of malignant pheochromocytoma and paraganglioma tumours - a single-centre study.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Aged; Aged, 80 and over; Child; Disease-Free Survival; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Paraganglioma; Patient Safety; Pheochromocytoma; Radiopharmaceuticals; Retrospective Studies; Young Adult | 2018 |
Imaging Characteristics of a Bladder Wall Paraganglioma.
Topics: 3-Iodobenzylguanidine; Aged; Humans; Male; Paraganglioma; Radiopharmaceuticals; Single Photon Emission Computed Tomography Computed Tomography; Urinary Bladder Neoplasms | 2019 |
[A CASE OF MALIGNANT PARAGANGLIOMA OF THE URINARY BLADDER TREATED WITH CYCLOPHOSPHAMIDE, VINCRISTINE, AND DACARBAZINE CHEMOTHERAPY AND METAIODOBENZYLGUANIDINE THERAPY].
Topics: 3-Iodobenzylguanidine; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cystectomy; Dacarbazine; Disease-Free Survival; Humans; Iodine Radioisotopes; Lymph Node Excision; Male; Neoplasm Recurrence, Local; Paraganglioma; Radiopharmaceuticals; Radiotherapy; Treatment Outcome; Urinary Bladder Neoplasms; Urinary Diversion; Vincristine | 2018 |
MIBG superscan of metastatic paraganglioma occurring with neurofibromatosis type 1.
Topics: 3-Iodobenzylguanidine; Female; Humans; Middle Aged; Neurofibromatosis 1; Octreotide; Paraganglioma; Pentetic Acid; Radionuclide Imaging; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
68Ga-DOTANOC PET/CT for baseline evaluation of patients with head and neck paraganglioma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Female; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Organometallic Compounds; Paraganglioma; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2013 |
SDHB gene positive metastatic paraganglioma associated with lesions which demonstrate both positive and negative uptake of 18FDG PET and 131MIBG.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Fluorodeoxyglucose F18; Genotype; Humans; Ireland; Male; Paraganglioma; Positron-Emission Tomography; Radiopharmaceuticals; Succinate Dehydrogenase | 2013 |
Systemic therapies for malignant pheochromocytoma and paraganglioma can exacerbate hypertension.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Blood Pressure; Disease Management; Drug Therapy; Enzyme Inhibitors; Humans; Hypertension; Paraganglioma; Pheochromocytoma; Protein-Tyrosine Kinases; Risk Factors | 2013 |
Prognostic values of initial responses to low-dose (131)I-MIBG therapy in patients with malignant pheochromocytoma and paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Prognosis; Radiation Dosage; Radiotherapy Dosage; Survival Analysis; Young Adult | 2013 |
First experience with image-guided resection of paraganglioma.
Topics: 3-Iodobenzylguanidine; Adult; Brain Neoplasms; Humans; Male; Paraganglioma; Radiopharmaceuticals; Surgery, Computer-Assisted; Tomography, Emission-Computed, Single-Photon | 2014 |
Effects and safety of ¹³¹I-metaiodobenzylguanidine (MIBG) radiotherapy in malignant neuroendocrine tumors: results from a multicenter observational registry.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Cohort Studies; Disease Progression; Female; Follow-Up Studies; Hospitals, University; Humans; Hypertension; Iodine Radioisotopes; Japan; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Registries | 2014 |
123I MIBG appearance of severe renal artery stenosis.
Topics: 3-Iodobenzylguanidine; Female; Humans; Middle Aged; Paraganglioma; Radiopharmaceuticals; Renal Artery Obstruction; Tomography, Emission-Computed | 2014 |
Management of metastatic phaeochromocytoma and paraganglioma: use of iodine-131-meta-iodobenzylguanidine therapy in a tertiary referral centre.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Disease Management; Female; Genetic Testing; Humans; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Radiopharmaceuticals; Retrospective Studies; Tertiary Care Centers; Treatment Outcome; Young Adult | 2015 |
Comparison of 131I-MIBG, 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT scans in a patient with extra adrenal paraganglioma associated with SDH-B gene mutation.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Mutation; Organometallic Compounds; Paraganglioma; Radionuclide Imaging; Radiopharmaceuticals; Succinate Dehydrogenase; Tomography, X-Ray Computed | 2015 |
Usefulness of Somatostatin Receptor Scintigraphy (Tc-[HYNIC, Tyr3]-Octreotide) and 123I-Metaiodobenzylguanidine Scintigraphy in Patients with SDHx Gene-Related Pheochromocytomas and Paragangliomas Detected by Computed Tomography.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Head and Neck Neoplasms; Heterozygote; Humans; Iodine Radioisotopes; Male; Middle Aged; Mutation; Octreotide; Paraganglioma; Pheochromocytoma; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Technetium; Tomography, X-Ray Computed; Young Adult | 2015 |
Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Catecholamines; Cell Membrane; Child; Chromaffin Cells; Female; Genotype; Humans; Liver; Male; Middle Aged; Mutation; Neurofibromin 1; Norepinephrine Plasma Membrane Transport Proteins; Paraganglioma; Pheochromocytoma; Proto-Oncogene Proteins c-ret; Radionuclide Imaging; Retrospective Studies; Succinate Dehydrogenase; Tomography, Emission-Computed, Single-Photon; Vesicular Monoamine Transport Proteins; Von Hippel-Lindau Tumor Suppressor Protein; Young Adult | 2015 |
68Ga-DOTATATE PET/MR Imaging of Urinary Bladder Paraganglioma.
Topics: 3-Iodobenzylguanidine; Adolescent; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Organometallic Compounds; Paraganglioma; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2015 |
Mediastinal paraganglioma.
Topics: 3-Iodobenzylguanidine; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mediastinal Neoplasms; Middle Aged; Paraganglioma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Much more than anxiety...
Topics: 3-Iodobenzylguanidine; Abdomen; Adolescent; Adrenal Gland Neoplasms; Adrenal Glands; Anxiety; Chromogranin A; Diagnosis, Differential; Female; Humans; Normetanephrine; Paraganglioma; Pheochromocytoma; Tomography, X-Ray Computed | 2015 |
Phaeochromocytomas and paragangliomas: A difference in disease behaviour and clinical outcomes.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Child; Combined Modality Therapy; Female; Follow-Up Studies; Heterocyclic Compounds; Humans; Male; Middle Aged; Neoplasm Staging; Organometallic Compounds; Paraganglioma; Pheochromocytoma; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tissue Distribution; Tomography, X-Ray Computed; Young Adult | 2015 |
Radiopharmaceuticals in paraganglioma imaging: too many members on board?
Topics: 3-Iodobenzylguanidine; Algorithms; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Mutation; Paraganglioma; Phenotype; Positron-Emission Tomography; Radiopharmaceuticals; Succinate Dehydrogenase | 2016 |
Successful Treatment of Coexisting Paraganglioma of the Retroperitoneum and Urinary Bladder by Intermediate-Dose 131I-MIBG Therapy: A Case Report.
Topics: 3-Iodobenzylguanidine; Adolescent; Antineoplastic Agents; Female; Humans; Paraganglioma; Radionuclide Imaging; Retroperitoneal Neoplasms; Urinary Bladder Neoplasms | 2015 |
Persistent Asymmetric Brain MIBG Activity Related to a Cerebrovascular Infarct.
Topics: 3-Iodobenzylguanidine; Adolescent; Brain Infarction; Carotid Body Tumor; Female; Humans; Paraganglioma; Radiopharmaceuticals | 2016 |
Transformation of a Nonfunctional Paraganglioma With I-123 MIBG Scintigraphy Correlation: A Case Report.
Topics: 3-Iodobenzylguanidine; Adult; Catecholamines; Female; Humans; Iodine Radioisotopes; Paraganglioma; Radionuclide Imaging; Radiopharmaceuticals; Retroperitoneal Neoplasms | 2016 |
MIBG Activity in the Gallbladder.
Topics: 3-Iodobenzylguanidine; Child; Female; Gallbladder; Humans; Neoplasm Metastasis; Paraganglioma; Single Photon Emission Computed Tomography Computed Tomography | 2016 |
[Hereditary phaeochromocytoma in twins].
Topics: 3-Iodobenzylguanidine; Adrenal Cortex; Adrenal Gland Neoplasms; Adrenalectomy; Biomarkers, Tumor; Catecholamines; Chromogranin A; Female; Germ-Line Mutation; Humans; Magnetic Resonance Imaging; Middle Aged; Organ Sparing Treatments; Paraganglioma; Pheochromocytoma; Radionuclide Imaging; Tomography, X-Ray Computed; Twins | 2016 |
Clinical Significance of Quantitative 123I-MIBG SPECT/CT Analysis of Pheochromocytoma and Paraganglioma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Aged, 80 and over; Ear Neoplasms; Female; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Paraganglioma; Phantoms, Imaging; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Retroperitoneal Neoplasms; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Single Photon Emission Computed Tomography Computed Tomography; Tomography, Emission-Computed, Single-Photon; Urinary Bladder Neoplasms; Young Adult | 2016 |
Laparoscopic resection of a paraganglioma in the organ of Zuckerkandl
Topics: 3-Iodobenzylguanidine; Adult; Endocrine Gland Neoplasms; Female; Humans; Laparoscopy; Para-Aortic Bodies; Paraganglioma; Radiopharmaceuticals; Surgery, Computer-Assisted | 2017 |
Peptide Receptor Radionuclide Treatment and (131)I-MIBG in the management of patients with metastatic/progressive phaeochromocytomas and paragangliomas.
Topics: 3-Iodobenzylguanidine; Acute Kidney Injury; Adrenal Gland Neoplasms; Adult; Aged; Chemotherapy, Adjuvant; Female; Humans; Male; Middle Aged; Octreotide; Organometallic Compounds; Paraganglioma; Pheochromocytoma; Radiopharmaceuticals; Retrospective Studies; Yttrium Radioisotopes | 2017 |
MIBG Localization of a Subclinical Paraganglioma of the Bladder.
Topics: 3-Iodobenzylguanidine; Adult; Female; Humans; Paraganglioma; Radiopharmaceuticals; Single Photon Emission Computed Tomography Computed Tomography; Urinary Bladder Neoplasms | 2017 |
Detection of metastatic lesions from malignant pheochromocytoma and paraganglioma with diffusion-weighted magnetic resonance imaging: comparison with 18F-FDG positron emission tomography and 123I-MIBG scintigraphy.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity | 2008 |
111In-octreotide is superior to 123I-metaiodobenzylguanidine for scintigraphic detection of head and neck paragangliomas.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Female; Head and Neck Neoplasms; Humans; Indium Radioisotopes; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Octreotide; Paraganglioma; Receptors, Somatostatin; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2008 |
6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine exces
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Biomarkers; Catecholamines; Child; Child, Preschool; Dihydroxyphenylalanine; Female; Humans; Hyperplasia; Magnetic Resonance Imaging; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2009 |
Usefulness of 123I-MIBG scintigraphy in the evaluation of patients with known or suspected primary or metastatic pheochromocytoma or paraganglioma: results from a prospective multicenter trial.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Aged; Aged, 80 and over; Europe; Female; Humans; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method; Young Adult | 2009 |
Utility of follow-up of 131I-MIBG scintigraphy to screen pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Humans; Iodine Radioisotopes; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Value of 123I-MIBG Scintigraphy in Paraganglioma.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adult; Aged; Female; Head and Neck Neoplasms; Humans; Indium Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Multiple Primary; Octreotide; Paraganglioma; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Thoracic Neoplasms; Tomography, X-Ray Computed; Young Adult | 2010 |
Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Genotype; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2009 |
Composite paraganglioma-ganglioneuroma in the retroperitoneum.
Topics: 3-Iodobenzylguanidine; Diagnosis, Differential; Female; Ganglioneuroma; Humans; Incidental Findings; Magnetic Resonance Imaging; Middle Aged; Paraganglioma; Radiopharmaceuticals; Retroperitoneal Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Increased urinary excretion of 3-methoxytyramine in patients with head and neck paragangliomas.
Topics: 3-Iodobenzylguanidine; Catecholamines; Cross-Sectional Studies; Dopamine; Female; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Paraganglioma; Prevalence; Radiography; Radionuclide Imaging; Up-Regulation | 2010 |
Pre-operative embolisation of metastatic paraganglioma of the thoracic spine.
Topics: 3-Iodobenzylguanidine; Angiography; Decompression, Surgical; Embolization, Therapeutic; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Paraganglioma; Radionuclide Imaging; Radiopharmaceuticals; Spinal Neoplasms; Thoracic Vertebrae | 2010 |
Paraganglioma syndrome type 1 in a patient with Carney-Stratakis syndrome.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Carney Complex; Chromogranin A; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Gene Transfer Techniques; Humans; Hypertension; Lymphatic Metastasis; Male; Metanephrine; Mutation; Neck; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Proto-Oncogene Proteins c-kit; Succinate Dehydrogenase; Syndrome; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2010 |
Dosimetry for 131I-MIBG therapies in metastatic neuroblastoma, phaeochromocytoma and paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Child; Humans; Neoplasm Metastasis; Neuroblastoma; Paraganglioma; Pheochromocytoma; Radiometry; Radiotherapy Dosage; Time Factors; Whole-Body Counting | 2010 |
Diagnosis: imaging of pheochromocytomas and paragangliomas.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Contrast Media; Diagnostic Imaging; Dihydroxyphenylalanine; Evaluation Studies as Topic; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transpo
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Biomarkers; Data Interpretation, Statistical; Dihydroxyphenylalanine; Female; Genetic Markers; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Vesicular Monoamine Transport Proteins; Young Adult | 2010 |
Functional paragangliomas of the urinary bladder: a report of 9 cases.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Aged; Catecholamines; Chromogranin A; Cystectomy; Female; Follow-Up Studies; Humans; Ki-67 Antigen; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paraganglioma; S100 Proteins; Tomography, X-Ray Computed; Urinary Bladder Neoplasms; Young Adult | 2010 |
68Ga-DOTA-TATE PET vs. 123I-MIBG in identifying malignant neural crest tumours.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Female; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Mutation; Organometallic Compounds; Paraganglioma; Positron-Emission Tomography; Retrospective Studies; Succinate Dehydrogenase; Young Adult | 2011 |
Comparison of diagnostic value of I-123 MIBG and high-dose I-131 MIBG scintigraphy including incremental value of SPECT/CT over planar image in patients with malignant pheochromocytoma/paraganglioma and neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Child; Dose-Response Relationship, Radiation; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Neuroblastoma; Paraganglioma; Pheochromocytoma; Radionuclide Imaging; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Neoplasm Staging; Paraganglioma; Paraganglioma, Extra-Adrenal; Pheochromocytoma; Positron-Emission Tomography; Recurrence; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Young Adult | 2011 |
Functional imaging of SDHx-related head and neck paragangliomas: comparison of 18F-fluorodihydroxyphenylalanine, 18F-fluorodopamine, 18F-fluoro-2-deoxy-D-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, and 111In-pentetreotide scintigraphy.
Topics: 3-Iodobenzylguanidine; Adult; Brain Mapping; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Paraganglioma; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Somatostatin; Succinate Dehydrogenase; Tomography, Emission-Computed | 2011 |
Image of the month--quiz case. Paraganglioma.
Topics: 3-Iodobenzylguanidine; Adult; Humans; Iodine Radioisotopes; Male; Paraganglioma; Radionuclide Imaging; Tomography, X-Ray Computed | 2011 |
Low-dose (123)I-metaiodobenzylguanidine diagnostic scan is inferior to (131)I-metaiodobenzylguanidine posttreatment scan in detection of malignant pheochromocytoma and paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Biological Transport; Female; Humans; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Radiation Dosage; Radionuclide Imaging; Reproducibility of Results; Time Factors; Whole Body Imaging | 2011 |
False-negative ¹²³I-MIBG SPECT is most commonly found in SDHB-related pheochromocytoma or paraganglioma with high frequency to develop metastatic disease.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; False Negative Reactions; Female; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Metanephrine; Middle Aged; Mutation; Paraganglioma; Pheochromocytoma; Prognosis; Proto-Oncogene Proteins c-ret; Radiopharmaceuticals; Succinate Dehydrogenase; Tomography, Emission-Computed, Single-Photon; Young Adult | 2012 |
Contrast- and non-contrast-enhanced ultrasonography (US) findings of hepatic metastasis from malignant pheochromocytoma/paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography | 2012 |
Repeated Radionuclide therapy in metastatic paraganglioma leading to the highest reported cumulative activity of 131I-MIBG.
Topics: 3-Iodobenzylguanidine; Humans; Iodine Radioisotopes; Paraganglioma; Radiopharmaceuticals; Retroperitoneal Neoplasms; Treatment Outcome | 2012 |
Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
A comparison of the performance of ⁶⁸Ga-DOTATATE PET/CT and ¹²³I-MIBG SPECT in the diagnosis and follow-up of phaeochromocytoma and paraganglioma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Follow-Up Studies; Humans; Middle Aged; Multimodal Imaging; Organometallic Compounds; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Young Adult | 2012 |
External beam radiation therapy (EBRT) for patients with malignant pheochromocytoma and non-head and -neck paraganglioma: combination with 131I-MIBG.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Combined Modality Therapy; Female; Humans; Iodine Radioisotopes; Male; Paraganglioma; Pheochromocytoma; Retrospective Studies; Young Adult | 2012 |
Toward tailored medicine (and beyond): the phaeochromocytoma and paraganglioma model.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Humans; Multimodal Imaging; Organometallic Compounds; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2012 |
The heart of the matter.
Topics: 3-Iodobenzylguanidine; Biomarkers, Tumor; Coronary Angiography; Dyspnea; Echocardiography; Fatigue; Genetic Testing; Heart Arrest; Heart Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Mutation; Paraganglioma; Radiopharmaceuticals; Stroke Volume; Succinate Dehydrogenase; Sweating; Tomography, X-Ray Computed | 2012 |
Primary pulmonary paraganglioma.
Topics: 3-Iodobenzylguanidine; Humans; Iodine Radioisotopes; Lung Neoplasms; Male; Middle Aged; Paraganglioma; Tomography, X-Ray Computed | 2002 |
[Secreting paraganglioma of the organ of Zuckerkandl. A case report].
Topics: 3-Iodobenzylguanidine; Back Pain; Catecholamines; Combined Modality Therapy; Diagnostic Imaging; Hemangioma; Humans; Iodine Radioisotopes; Laminectomy; Lumbar Vertebrae; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Multiple Primary; Para-Aortic Bodies; Paraganglioma; Radioisotope Teletherapy; Radiotherapy, Adjuvant; Retroperitoneal Neoplasms; Spinal Cord Compression; Spinal Neoplasms; Thoracic Vertebrae; Vascular Neoplasms; Vena Cava, Inferior | 2002 |
Paraganglioma of the urinary bladder: a case report.
Topics: 3-Iodobenzylguanidine; Adult; Humans; Male; Paraganglioma; Urinary Bladder Neoplasms | 2003 |
High-dose 131I-metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Antineoplastic Agents; Child; Dose-Response Relationship, Radiation; Female; Humans; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Treatment Outcome | 2003 |
Iodine -131 metaiodobenzylguanidine is an effective treatment for malignant pheochromocytoma and paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Dose-Response Relationship, Radiation; Female; Humans; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Radiopharmaceuticals; Retrospective Studies; Survival Analysis | 2003 |
Case report: drug interference with MIBG uptake in a patient with metastatic paraganglioma.
Topics: 3-Iodobenzylguanidine; Adult; Antineoplastic Agents; Drug Interactions; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Methadone; Narcotics; Paraganglioma; Radiopharmaceuticals; Substance-Related Disorders; Tomography, Emission-Computed | 2004 |
Long-term efficacy of doxazosin plus atenolol in the management of severe and sustained arterial hypertension and reversibility of the cardiac damage induced by chronic cathecolamine excess. A case report in a young girl with recurrent, functioning paraga
Topics: 3-Iodobenzylguanidine; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Atenolol; Blood Pressure; Catecholamines; Child; Doxazosin; Drug Therapy, Combination; Electrocardiography; Female; Heart Diseases; Heart Neoplasms; Heart Rate; Humans; Hypertension; Hypertrophy, Left Ventricular; Para-Aortic Bodies; Paraganglioma; Radionuclide Imaging; Radiopharmaceuticals | 2004 |
[Paragangliomas: clinical and secretory profile. Result of 39 cases].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Antineoplastic Agents; Catecholamines; Female; Humans; Male; Paraganglioma; Retrospective Studies; Treatment Outcome | 2005 |
The importance of the interpretation of urine catecholamines is essential for the diagnosis and management of patient with dopamine-secreting paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Aged; Carcinoma, Non-Small-Cell Lung; Dopamine; Epinephrine; Female; Humans; Iodine Radioisotopes; Lung Neoplasms; Norepinephrine; Paraganglioma; Tomography, X-Ray Computed | 2005 |
Bilateral pheochromocytoma associated with paraganglioma and papillary thyroid carcinoma: report of an unusual case.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Biopsy, Needle; Carcinoma, Papillary; Female; Humans; Lymph Node Excision; Multiple Endocrine Neoplasia; Paraganglioma; Pheochromocytoma; Proto-Oncogene Mas; Radiopharmaceuticals; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Ultrasonography | 2007 |
Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Dopamine; Female; Fluorodeoxyglucose F18; Germ-Line Mutation; Humans; Iron-Sulfur Proteins; Male; Middle Aged; Neoplasm Metastasis; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Succinate Dehydrogenase | 2007 |
Whole-body iodine-131 metaiodobenzylguanidine imaging for detection of bone metastases in patients with paraganglioma: comparison with bone scintigraphy.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Bone and Bones; Bone Neoplasms; Female; Humans; Iodine Radioisotopes; Neoplasm Metastasis; Neuroendocrine Tumors; Paraganglioma; Radionuclide Imaging; Radiopharmaceuticals; Whole Body Imaging | 2007 |
Outcomes of pheochromocytoma management in the laparoscopic era.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aged; Aged, 80 and over; Child; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Laparoscopy; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Paraganglioma; Pheochromocytoma; Retrospective Studies; Tomography, X-Ray Computed | 2007 |
131I-MIBG therapy in metastatic phaeochromocytoma and paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Antineoplastic Agents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Retrospective Studies; Survival Analysis; Thoracic Neoplasms; Tomography, X-Ray Computed | 2008 |
Discrepancy between glucose metabolism and sympathetic nerve terminals in a patient with metastatic paraganglioma.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adult; Blood Glucose; Fluorodeoxyglucose F18; Humans; Male; Paraganglioma; Radionuclide Imaging; Sympathetic Nervous System | 2008 |
Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Iron-Sulfur Proteins; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Prognosis; Radionuclide Imaging; Retrospective Studies; Succinate Dehydrogenase; Tomography, Emission-Computed | 2008 |
[Anesthetic management in a case of recurrent mediastinal paraganglioma].
Topics: 3-Iodobenzylguanidine; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthesia, General; Combined Modality Therapy; Female; Fluid Therapy; Humans; Hypertension; Intraoperative Complications; Iodine Radioisotopes; Mediastinal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Paraganglioma; Phenoxybenzamine; Preanesthetic Medication; Propranolol; Spinal Fusion; Spinal Neoplasms; Thoracic Vertebrae; Thoracotomy | 2008 |
[Sympathetic paraganglioma. Scintigraphic detection using a new labeled molecule, meta-iodobenzylguanidine].
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adrenal Gland Neoplasms; Adult; Bone and Bones; Bone Neoplasms; Catecholamines; Female; Ganglia, Sympathetic; Humans; Iodine Radioisotopes; Iodobenzenes; Paraganglioma; Pheochromocytoma; Radionuclide Imaging; Sympatholytics | 1984 |
Meta-[I-131]iodobenzylguanidine uptake in a nonsecreting paraganglioma.
Topics: 3-Iodobenzylguanidine; Aged; Carotid Arteries; Catecholamines; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Paraganglioma; Radiography; Radionuclide Imaging | 1984 |
Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Female; Ganglioneuroblastoma; Humans; Indium Radioisotopes; Iodine Radioisotopes; Iodobenzenes; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Octreotide; Paraganglioma; Pentetic Acid; Pheochromocytoma; Radionuclide Imaging; Tomography, X-Ray Computed | 1995 |
A case of complete Carney's syndrome.
Topics: 3-Iodobenzylguanidine; Chondroma; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Leiomyosarcoma; Lung Neoplasms; Middle Aged; Neoplasms, Multiple Primary; Paraganglioma; Stomach Neoplasms; Sympatholytics; Syndrome; Thoracic Neoplasms; Tomography, Emission-Computed, Single-Photon | 1994 |
Normal cerebellar MIBG localization. Implications in the interpretation of delayed scans.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Antineoplastic Agents; Cerebellum; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Paraganglioma; Radionuclide Imaging; Time Factors | 1994 |
[Scintigraphy with iodine-131 metaiodobenzylguanidine in the study of paraganglioma. Comparison between benign and malignant tumors].
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Diagnosis, Differential; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Paraganglioma; Radionuclide Imaging | 1994 |
Treatment of malignant phaeochromocytoma, paraganglioma and carcinoid tumours with 131I-metaiodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Antineoplastic Agents; Carcinoid Tumor; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Paraganglioma; Pheochromocytoma | 1993 |
Utility of thallium-201 and iodine-123 metaiodobenzylguanidine in the scintigraphic detection of neuroendocrine neoplasia.
Topics: 3-Iodobenzylguanidine; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Neuroendocrine Tumors; Paraganglioma; Pheochromocytoma; Radionuclide Imaging; Thallium Radioisotopes; Thyroid Neoplasms | 1993 |
Iodine-131-metaiodobenzylguanidine scintigraphy in preoperative and postoperative evaluation of paragangliomas: comparison with CT and MRI.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Magnetic Resonance Imaging; Male; Middle Aged; Paraganglioma; Paraganglioma, Extra-Adrenal; Radionuclide Imaging; Tomography, X-Ray Computed | 1993 |
Greetings from below the aortic arch! The paradigm of cardiac paraganglioma.
Topics: 3-Iodobenzylguanidine; Contrast Media; Echocardiography, Transesophageal; Female; Heart Neoplasms; Humans; Iodobenzenes; Magnetic Resonance Imaging; Middle Aged; Paraganglioma; Radionuclide Imaging | 1996 |
The usefulness of cardio-vascular visualization in the localization of mediastinal pheochromocytomas with I-131-MIBG.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Cardiovascular System; Humans; Iodine Radioisotopes; Iodobenzenes; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Paraganglioma; Pheochromocytoma; Radionuclide Imaging | 1996 |
Questionability of the benefits of routine laparotomy as the surgical approach for pheochromocytomas and abdominal paragangliomas.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Contrast Media; Evaluation Studies as Topic; Female; Humans; Iodobenzenes; Laparotomy; Magnetic Resonance Imaging; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Radionuclide Imaging; Tomography, X-Ray Computed | 1996 |
Meta-[131I]iodobenzylguanidine in the scintigraphic evaluation of neural crest tumors.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Carcinoid Tumor; Carcinoma, Medullary; Child; False Negative Reactions; False Positive Reactions; Follow-Up Studies; Heart; Humans; Hyperaldosteronism; Injections, Intravenous; Insulinoma; Iodine Radioisotopes; Iodobenzenes; Middle Aged; Myocardium; Neuroblastoma; Neuroendocrine Tumors; Pancreatic Neoplasms; Paraganglioma; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Salivary Glands; Sensitivity and Specificity; Thyroid Neoplasms | 1995 |
Diagnostic imaging in patients with paragangliomas. Computed tomography, magnetic resonance and MIBG scintigraphy comparison.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Contrast Media; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Magnetic Resonance Imaging; Male; Paraganglioma; Pheochromocytoma; Sensitivity and Specificity; Tomography, X-Ray Computed | 1996 |
Renal excretion of iodine-131 labelled meta-iodobenzylguanidine and metabolites after therapeutic doses in patients suffering from different neural crest-derived tumours.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Aged; Carcinoid Tumor; Child; Child, Preschool; Contrast Media; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Iodohippuric Acid; Kidney; Male; Middle Aged; Neuroblastoma; Paraganglioma; Pheochromocytoma | 1997 |
Multifocal paragangliomas depicted by I-123 metaiodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Adult; Humans; Iodine Radioisotopes; Male; Multiple Endocrine Neoplasia; Paraganglioma; Radionuclide Imaging; Radiopharmaceuticals | 1998 |
[Congenital cyanotic heart disease and peripheral neurogenic tumor].
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adolescent; Chronic Disease; Dextrocardia; Epilepsy, Tonic-Clonic; Fatal Outcome; Heart Defects, Congenital; Humans; Hypertension; Hypertension, Renovascular; Hypoxia; Male; Metanephrine; Paraganglioma; Pentetic Acid; Pulmonary Edema; Renal Artery; Situs Inversus; Tomography, Emission-Computed, Single-Photon | 1999 |
Malignant human renin producing paraganglionoma-localization with 123I-MIBG and treatment with 131I-MIBG.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Fatal Outcome; Female; Humans; Iodine Radioisotopes; Neoplasm Proteins; Paraganglioma; Radionuclide Imaging; Radiopharmaceuticals; Renin | 1999 |
Resection of a branchiomeric paraganglioma at a rare extrapulmonary location.
Topics: 3-Iodobenzylguanidine; Adult; Branchial Region; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Norepinephrine; Paraganglioma; Radiopharmaceuticals | 2000 |
Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Carcinoid Tumor; Child; Female; Humans; Indium Radioisotopes; Insulinoma; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neuroendocrine Tumors; Pancreatic Neoplasms; Paraganglioma; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Somatostatin; Thyroid Neoplasms; Tomography, X-Ray Computed | 2001 |
Functional imaging as an aid to decision-making in metastatic paraganglioma.
Topics: 3-Iodobenzylguanidine; Adult; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Paraganglioma; Radionuclide Imaging; Radiopharmaceuticals | 2001 |
Functional imaging of malignant paragangliomas and carcinoid tumours.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Paraganglioma; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG].
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoid Tumor; Carcinoma, Medullary; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neuroendocrine Tumors; Paraganglioma; Pheochromocytoma; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Thyroid Neoplasms; Treatment Outcome | 2001 |
Paraganglioma seen with FDG dual-head gamma camera coincidence imaging after false-negative results of I-123 MIBG imaging.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Paraganglioma; Radionuclide Imaging; Radiopharmaceuticals | 2001 |
Paraganglioma of the pituitary fossa: diagnosis and management.
Topics: 3-Iodobenzylguanidine; Combined Modality Therapy; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Paraganglioma; Pituitary Neoplasms; Radiopharmaceuticals; Radiosurgery; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2001 |
Malignant paraganglioma of the mediastinum: a further diagnostic and therapeutic use of radiolabelled mIBG.
Topics: 3-Iodobenzylguanidine; Adult; Antineoplastic Agents; Bone Neoplasms; Contrast Media; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Mediastinal Neoplasms; Paraganglioma; Radionuclide Imaging; Ribs; Spinal Neoplasms; Thoracic Vertebrae | 1992 |
Treatment of metastatic para-aortic paraganglioma by surgery, radiotherapy and I-131 mIBG.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Combined Modality Therapy; Humans; Iodine Radioisotopes; Iodobenzenes; Laminectomy; Male; Middle Aged; Para-Aortic Bodies; Paraganglioma; Spinal Cord Compression; Spinal Neoplasms; Sympatholytics | 1991 |
Consolidating the role of *I-MIBG-scintigraphy in childhood neuroblastoma: five years of clinical experience.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Child; Child, Preschool; Eye Neoplasms; Female; Humans; Infant; Infant, Newborn; Iodine Radioisotopes; Iodobenzenes; Liver Neoplasms; Male; Methods; Neuroblastoma; Paraganglioma; Radionuclide Imaging; Retinoblastoma; Thoracic Neoplasms | 1990 |
Localization and treatment of familial malignant nonfunctional paraganglioma with iodine-131 MIBG: report of two cases.
Topics: 3-Iodobenzylguanidine; Adult; Bone Neoplasms; Brain Neoplasms; Carotid Body; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Neoplasm Invasiveness; Neoplasm Metastasis; Palliative Care; Paraganglioma; Radionuclide Imaging; Radiotherapy Dosage | 1987 |
Pre- and post-treatment distribution pattern of 123I-MIBG in patients with phaeochromocytomas and paragangliomas.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Catecholamines; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Metabolic Clearance Rate; Middle Aged; Paraganglioma; Pheochromocytoma; Radionuclide Imaging; Tissue Distribution | 1989 |
Imaging neural crest tumours with 123I-metaiodobenzylguanidine and X-ray computed tomography: a comparative study.
Topics: 3-Iodobenzylguanidine; Adult; Ganglioneuroma; Humans; Iodine Radioisotopes; Iodobenzenes; Neoplasms, Nerve Tissue; Neuroblastoma; Paraganglioma; Pheochromocytoma; Radionuclide Imaging; Retrospective Studies; Tomography, X-Ray Computed | 1988 |
Experience with I-131-metaiodobenzylguanidine (MIBG): a retrospective study.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Child; Diagnostic Errors; Humans; Iodine Radioisotopes; Iodobenzenes; Liver Neoplasms; Middle Aged; Multiple Endocrine Neoplasia; Neurilemmoma; Neuroblastoma; Paraganglioma; Pheochromocytoma; Radionuclide Imaging; Retrospective Studies | 1987 |
Iodine-131 MIBG scintigraphy of neuroendocrine tumors other than pheochromocytoma and neuroblastoma.
Topics: 3-Iodobenzylguanidine; Aged; Apudoma; Carcinoid Tumor; Carcinoma; Carotid Body Tumor; Choriocarcinoma; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Neurilemmoma; Paraganglioma; Paraganglioma, Extra-Adrenal; Pregnancy; Radionuclide Imaging; Thyroid Neoplasms | 1987 |
Therapeutic effectiveness of iodine-131 MIBG metastases of a nonsecreting paraganglioma.
Topics: 3-Iodobenzylguanidine; Adult; Bone Neoplasms; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Paraganglioma; Retroperitoneal Neoplasms | 1988 |
Cervical catecholamine-secreting paraganglioma in the pterygopalatine fossa.
Topics: 3-Iodobenzylguanidine; Adult; Brain Neoplasms; Catecholamines; Humans; Hypertension; Iodine Radioisotopes; Iodobenzenes; Male; Paraganglioma | 1987 |
Uptake of iodine-123 MIBG by pheochromocytomas, paragangliomas, and neuroblastomas: a histopathological comparison.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Cytoplasmic Granules; Female; Ganglioneuroma; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Radionuclide Imaging | 1987 |
Observations on the function of normal adrenomedullary tissue in patients with phaeochromocytomas and other paragangliomas.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenal Medulla; Humans; Iodine Radioisotopes; Iodobenzenes; Paraganglioma; Pheochromocytoma; Radionuclide Imaging | 1987 |
Paraganglioma of urinary bladder, visualization with 131I-MIBG scintigraphy.
Topics: 3-Iodobenzylguanidine; Adult; Child; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Paraganglioma; Radionuclide Imaging; Tomography, X-Ray Computed; Urinary Bladder; Urinary Bladder Neoplasms | 1987 |
Pheochromocytoma and paraganglioma: comparison of MR imaging with CT and I-131 MIBG scintigraphy.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenal Glands; Bone Neoplasms; Evaluation Studies as Topic; Humans; Iodine Radioisotopes; Iodobenzenes; Liver Neoplasms; Magnetic Resonance Spectroscopy; Neoplasm Recurrence, Local; Paraganglioma; Pheochromocytoma; Prospective Studies; Radionuclide Imaging; Retroperitoneal Neoplasms; Tomography, X-Ray Computed | 1987 |
Paraganglioma of the heart. The value of magnetic resonance imaging in the preoperative evaluation.
Topics: 3-Iodobenzylguanidine; Heart Neoplasms; Humans; Iodine Radioisotopes; Iodobenzenes; Magnetic Resonance Spectroscopy; Male; Middle Aged; Paraganglioma; Tomography, X-Ray Computed | 1986 |
Use of 131I-MIBG scintigraphy in the evaluation of suspected pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Bone Neoplasms; Child; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Paraganglioma; Pheochromocytoma; Radionuclide Imaging; Time Factors; Tomography, X-Ray Computed | 1985 |
Localization of mediastinal paragangliomas (pheochromocytoma).
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Echocardiography; Humans; Iodine Radioisotopes; Iodobenzenes; Mediastinal Neoplasms; Paraganglioma; Pheochromocytoma; Tomography, X-Ray Computed | 1985 |